FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080778814> ?p ?o ?g. }

• W3080778814 endingPage "190" @default.
• W3080778814 startingPage "189" @default.
• W3080778814 abstract "A novel coronavirus pneumonia named coronavirus disease 2019 (COVID-19) resulted in an epidemic all over the world.1 As a consequence, it is urgent to develop an effective treatment process to manage those patients with severe COVID-19 infection. The early introduction of extracorporeal organ support (ECOS) can play a critical role in controlling patients with severe pneumonia. However, the morbidity of COVID-19 infection is higher than SARS and about 14% of patients have developed severe complications within a week, such as acute respiratory distress syndrome (ARDS), septic shock, and even multiple organ failure (MOF).2 According to the experience from the front lines of COVID-19 infection, to prevent patients from developing those complications, ECOS must be applied with the least delay possible to increase the survival rate and save patients’ lives. If standard treatments are useless, mechanical ventilation with the prone position should be introduced immediately. If patients’ status continues to deteriorate, the observation period in the indications for ECMO, which is mainly based on CESAR or EOLIA standards, needs to be shortened in favor of an early ECMO insertion, following the principle of lung-protective ventilation (Table 1). The multistage drainage tubes should not be applied in venous drainage because these tubes can lead to poor drainage and impede ECMO flow effects. Patients with severe COVID-19 infection may be correlated to myocardial injury, arrhythmias, and even cardiogenic shock. If hemodynamic instability appears for a period of time, V-A ECMO should be inserted for recovery. The cytokine expression of patients with severe COVID-19 infection, including IL-2, MCP-1, TNF-α, and IL-6, are significantly higher, may lead to cytokine storm, and even MOF.3 The early introduction of ECMO can also induce the inflammatory cytokines release, resulting in ECMO-related SIRS.4 Therefore, the blood cytokines, especially those cytokines above mentioned, should be monitored frequently during the ECMO period, and novel extracorporeal organ support therapies, such as hemoperfusion and ECMO with novel coating-canal, may be a better way to remove cytokines and other circulating mediators. To reduce the risk of virus exposure in clinical practice, the early parallel connection of CRRT machines to the ECMO pipeline is applied if the patients with severe COVID-19 infection and ECMO therapy have septic shock or severe acute renal injury. Compared with the survivors, the morbidity of disseminated intravascular coagulation (DIC) in non-survivors has reached 71.4%. DIC is often associated with hepatic insufficiency, which may be associated with severe ARDS and MOF, and become the trigger for several pathological pathways. For those patients with DIC or bleeding, the artificial extracorporeal liver support should be introduced early to decrease the incidence of ECMO complications and in-hospital mortality. Overall, patients with severe COVID-19 infection are in critical condition with rapid disease progression and high mortality. ECOS should be applied as soon as possible to improve the survival rate. To lessen the complications, the patients who are undergoing such a complex therapy may still require additional organ support. This research was supported by the grant from the Natural Science Foundation of Tianjin (Grand No: 19JCYBJC2600)." @default.
• W3080778814 created "2020-09-01" @default.
• W3080778814 creator A5026316016 @default.
• W3080778814 creator A5039145467 @default.
• W3080778814 creator A5089446912 @default.
• W3080778814 date "2020-08-24" @default.
• W3080778814 modified "2023-09-25" @default.
• W3080778814 title "The treatment of extracorporeal organ support for critical ill patients with coronavirus disease 2019: A brief perspective from the front line" @default.
• W3080778814 cites W1887116967 @default.
• W3080778814 cites W3001118548 @default.
• W3080778814 cites W3009155494 @default.
• W3080778814 cites W3165656738 @default.
• W3080778814 doi "https://doi.org/10.1111/aor.13785" @default.
• W3080778814 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7461011" @default.
• W3080778814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32839961" @default.
• W3080778814 hasPublicationYear "2020" @default.
• W3080778814 type Work @default.
• W3080778814 sameAs 3080778814 @default.
• W3080778814 citedByCount "3" @default.
• W3080778814 countsByYear W30807788142020 @default.
• W3080778814 countsByYear W30807788142021 @default.
• W3080778814 countsByYear W30807788142022 @default.
• W3080778814 crossrefType "journal-article" @default.
• W3080778814 hasAuthorship W3080778814A5026316016 @default.
• W3080778814 hasAuthorship W3080778814A5039145467 @default.
• W3080778814 hasAuthorship W3080778814A5089446912 @default.
• W3080778814 hasBestOaLocation W30807788141 @default.
• W3080778814 hasConcept C126322002 @default.
• W3080778814 hasConcept C141071460 @default.
• W3080778814 hasConcept C177713679 @default.
• W3080778814 hasConcept C2776348555 @default.
• W3080778814 hasConcept C2776850375 @default.
• W3080778814 hasConcept C2776858399 @default.
• W3080778814 hasConcept C2777080012 @default.
• W3080778814 hasConcept C2777628635 @default.
• W3080778814 hasConcept C2777714996 @default.
• W3080778814 hasConcept C2777914695 @default.
• W3080778814 hasConcept C2778384902 @default.
• W3080778814 hasConcept C2779915274 @default.
• W3080778814 hasConcept C42219234 @default.
• W3080778814 hasConcept C500558357 @default.
• W3080778814 hasConcept C71924100 @default.
• W3080778814 hasConceptScore W3080778814C126322002 @default.
• W3080778814 hasConceptScore W3080778814C141071460 @default.
• W3080778814 hasConceptScore W3080778814C177713679 @default.
• W3080778814 hasConceptScore W3080778814C2776348555 @default.
• W3080778814 hasConceptScore W3080778814C2776850375 @default.
• W3080778814 hasConceptScore W3080778814C2776858399 @default.
• W3080778814 hasConceptScore W3080778814C2777080012 @default.
• W3080778814 hasConceptScore W3080778814C2777628635 @default.
• W3080778814 hasConceptScore W3080778814C2777714996 @default.
• W3080778814 hasConceptScore W3080778814C2777914695 @default.
• W3080778814 hasConceptScore W3080778814C2778384902 @default.
• W3080778814 hasConceptScore W3080778814C2779915274 @default.
• W3080778814 hasConceptScore W3080778814C42219234 @default.
• W3080778814 hasConceptScore W3080778814C500558357 @default.
• W3080778814 hasConceptScore W3080778814C71924100 @default.
• W3080778814 hasIssue "2" @default.
• W3080778814 hasLocation W30807788141 @default.
• W3080778814 hasLocation W30807788142 @default.
• W3080778814 hasOpenAccess W3080778814 @default.
• W3080778814 hasPrimaryLocation W30807788141 @default.
• W3080778814 hasRelatedWork W2081913667 @default.
• W3080778814 hasRelatedWork W2140018468 @default.
• W3080778814 hasRelatedWork W2153885496 @default.
• W3080778814 hasRelatedWork W2224603377 @default.
• W3080778814 hasRelatedWork W2739819551 @default.
• W3080778814 hasRelatedWork W2796212195 @default.
• W3080778814 hasRelatedWork W2944215115 @default.
• W3080778814 hasRelatedWork W3082071707 @default.
• W3080778814 hasRelatedWork W3134178833 @default.
• W3080778814 hasRelatedWork W4200392079 @default.
• W3080778814 hasVolume "45" @default.
• W3080778814 isParatext "false" @default.
• W3080778814 isRetracted "false" @default.
• W3080778814 magId "3080778814" @default.
• W3080778814 workType "article" @default.